Dudediligence.

Q/C Technologies, Inc

QCLSNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Price

From the filings

Figures

Net income
−$16.6Mlast 12 months
Operating cash flow
−$9.7Mlast 12 months
Cash and equivalents
$307,612at the last balance sheet
Shares outstanding
8.2M shareson issue
Every year and quarter →